Glaxo Pays Up

GlaxoSmithKline has agreed to pay $750 million to settle several lawsuits stemming from whistleblower complaints about the company knowingly selling contaminated baby ointment and an ineffective antidepressant, report the New York Times' Gardiner Harris and Duff Wilson. Glaxo sold 20 drugs — including antidepressant Paxil, diabetes drug Avandia, and heart drug Coreg — manufactured at a plant that had contamination problems for many years, Gardiner and Wilson say.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.